Mechanisms underlying the radioprotective effect of histamine on small intestine

• Published in: International journal of radiation biology Vol. 83; no. 10; pp. 653 - 663
• Main Authors: Medina, Vanina A., Croci, Máximo, Mohamad, Nora A., Massari, Noelia, Garbarino, Gloria, Cricco, Graciela P., Núñez, Mariel A., Martín, Gabriela A., Crescenti, Ernesto J. V., Bergoc, Rosa M., Rivera, Elena S.
• Format: Journal Article
• Language: English
• Published: England Informa UK Ltd 01.01.2007; Taylor & Francis
• Subjects: Animals; antioxidant enzymes; apoptosis; Apoptosis - drug effects; Cell Nucleus - pathology; Cell Proliferation - drug effects; Cesium Isotopes - metabolism; Cytoplasm - pathology; Edema - pathology; Histamine; Histamine - administration & dosage; Histamine - pharmacology; Immunohistochemistry; Injections, Subcutaneous; Intestinal Diseases - drug therapy; Intestinal Diseases - pathology; Intestinal Diseases - radiotherapy; Intestine, Small - drug effects; Intestine, Small - pathology; Intestine, Small - radiation effects; ionizing radiation; Mice; Mice, Nude; Peroxidases - metabolism; Proliferating Cell Nuclear Antigen - metabolism; Radiation Injuries, Experimental - drug therapy; Radiation Injuries, Experimental - prevention & control; Radiation Injuries, Experimental - veterinary; radioprotectant; small intestine; Time Factors; Whole-Body Irradiation
• ISSN: 0955-3002; 1362-3095
• DOI: 10.1080/09553000701570238

Purpose: To examine the protective effects of histamine on intestinal damage produced by gamma-radiation. Materials and methods: 56 mice were divided into 4 groups. Histamine and Histamine-10 Gy groups received a daily subcutaneous histamine injection (0.1 mg kg) starting 20 hours before irradiation and continued until the end of the experimental period; the untreated group received saline. Histamine-10 Gy and untreated-10 Gy groups were irradiated with a single dose on whole-body using Cesium-137 source (7 Gy min) and were sacrificed 3 days after irradiation. Small intestine was removed, fixed and stained with hematoxylin and eosin. The number of intestinal crypts per circumference, and other histological characteristics of intestinal cells were evaluated. We further determined by immunohistochemistry the expression of proliferating cell nuclear antigen (PCNA), Bax, Bcl-2 (pro- and anti-apoptotic protein, respectively), antioxidant enzymes (Superoxide dismutase (SOD), Catalase and Glutathione peroxidase), histamine content and apoptosis by terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate biotin nick end labeling (TUNEL) assay. Cells in the S phase of the cell cycle were identified by immunohistochemical detection of 5-bromo-2′-deoxyuridine (BrdU) incorporation. Results: Histamine treatment reduced mucosal atrophy, edema and preserved villi, crypts and nuclear and cytoplasmic characteristics of small intestine after radiation exposure. Additionally, histamine treatment increased PCNA expression and the BrdU-positive cell number, histamine content, decreased the number of apoptotic cells and significantly increased Catalase and copper-zinc-containing SOD of irradiated mice. Conclusions: Histamine prevents radiation-induced toxicity by increasing proliferation of damaged intestinal mucosa and suppressing apoptosis that was associated with an increase in SOD and Catalase levels. This effect might be of clinical value in patients undergoing radiotherapy.